JGS-13525-43974 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-06-30
Registered in v-safe
2022-06-30
Dose 1 — Pfizer-BioNTech
2022-06-30
Health check-in — day 0, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-07-01
Survey response — days 1–6 daily, dose 1, under 3
MedDRA: Flatulence, Initial insomnia — Feeling: Good

Free text: Much more gassy than usual and had trouble falling asleep last night

MedDRA releases: 2024-11 · check-in free text available
2022-07-02
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-07-04
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-07-05
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-07-06
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-07-07
Health check-in — day 7, dose 1, under 3
Feeling: Good · Irritability/crying

Under 3 check-in
2022-07-16
Health check-in — day 14, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-07-21
Dose 2 — Pfizer-BioNTech
2022-07-21
Health check-in — day 21, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-07-27
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-07-28
Health check-in — day 7, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-08-04
Health check-in — day 14, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-08-11
Health check-in — day 21, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-08-20
Health check-in — day 28, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-08-25
Health check-in — day 35, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-09-01
Survey response — day 42, dose 2, under 3
MedDRA: Cough, Nasopharyngitis, Respiratory tract congestion, SARS-CoV-2 test negative — Feeling: Good

Free text: Cold symptoms (congestion, occasional cough, but negative Covid test)

MedDRA releases: 2024-11 · check-in free text available
2022-10-20
Survey response — 3 months, dose 2, under 3
MedDRA: Cough, Respiratory tract congestion — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Congestion and a bit of a cough, especially overnight

MedDRA releases: 2024-11 · check-in free text available
2023-01-19
Health check-in — 6 months, dose 2, under 3
Feeling: Good

Under 3 check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-06-30	Pfizer-BioNTech	No
2	2022-07-21	Pfizer-BioNTech	No

Free text

Release 12 (Under 3) — days 1–6 daily, dose 1, under 3

2022-07-01

Systemic reaction (other): Much more gassy than usual and had trouble falling asleep last night

Release 12 (Under 3) — day 42, dose 2, under 3

2022-09-01

Symptoms: Cold symptoms (congestion, occasional cough, but negative Covid test)

Release 12 (Under 3) — 3 months, dose 2, under 3

2022-10-20

Symptoms: Congestion and a bit of a cough, especially overnight

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	·	·	✓
SD	Nasopharyngitis	·	·	✓
SD	Respiratory tract congestion	·	·	✓
SD	SARS-CoV-2 test negative	·	·	✓
SRO	Flatulence	·	·	✓
SRO	Initial insomnia	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release